Sampat Sindhar1, Michael Lugo1, Mark D Levin2, Joshua R Danback1, Benjamin D Brink3, Eric Yu3, Dennis J Dietzen1, Amy L Clark1, Carolyn A Purgert1, Jessica L Waxler4, Robert W Elder5, Barbara R Pober6, Beth A Kozel7. 1. Department of Pediatrics, Washington University School of Medicine, St. Louis, MO. 2. National Institutes of Health, National Heart, Lung, and Blood Institute, Bethesda, MD. 3. Frank H. Netter School of Medicine, Quinnipiac University, North Haven, CT. 4. Massachusetts General Hospital, Boston, MA. 5. Section of Cardiology, Departments of Pediatrics and Internal Medicine, Yale University School of Medicine, New Haven, CT. 6. Frank H. Netter School of Medicine, Quinnipiac University, North Haven, CT; Massachusetts General Hospital, Boston, MA; Harvard Medical School, Boston, MA. 7. Department of Pediatrics, Washington University School of Medicine, St. Louis, MO; National Institutes of Health, National Heart, Lung, and Blood Institute, Bethesda, MD. Electronic address: beth.kozel@nih.gov.
Abstract
OBJECTIVE: To evaluate the timing, trajectory, and implications of hypercalcemia in Williams-Beuren syndrome (WBS) through a multicenter retrospective study. STUDY DESIGN: Data on plasma calcium levels from 232 subjects with WBS aged 0-67.1 years were compared with that in controls and also with available normative data. Association testing was used to identify relevant comorbidities. RESULTS: On average, individuals with WBS had higher plasma calcium levels than controls, but 86.7% of values were normal. Nonpediatric laboratories overreport hypercalcemia in small children. When pediatric reference intervals were applied, the occurrence of hypercalcemia dropped by 51% in infants and by 38% in toddlers. Across all ages, 6.1% of the subjects had actionable hypercalcemia. In children, actionable hypercalcemia was seen in those aged 5-25 months. In older individuals, actionable hypercalcemia was often secondary to another disease process. Evidence of dehydration, hypercalciuria, and nephrocalcinosis were common in both groups. Future hypercalcemia could not be reliably predicted by screening calcium levels. A subgroup analysis of 91 subjects found no associations between hypercalcemia and cardiovascular disease, gastrointestinal complaints, or renal anomalies. Analyses of electrogradiography data showed an inverse correlation of calcium concentration with corrected QT interval, but no acute life-threatening events were reported. CONCLUSIONS: Actionable hypercalcemia in patients with WBS occurs infrequently. Although irritability and lethargy were commonly reported, no mortality or acute life-threatening events were associated with hypercalcemia and the only statistically associated morbidities were dehydration, hypercalciuria, and nephrocalcinosis. Published by Elsevier Inc.
OBJECTIVE: To evaluate the timing, trajectory, and implications of hypercalcemia in Williams-Beuren syndrome (WBS) through a multicenter retrospective study. STUDY DESIGN: Data on plasma calcium levels from 232 subjects with WBS aged 0-67.1 years were compared with that in controls and also with available normative data. Association testing was used to identify relevant comorbidities. RESULTS: On average, individuals with WBS had higher plasma calcium levels than controls, but 86.7% of values were normal. Nonpediatric laboratories overreport hypercalcemia in small children. When pediatric reference intervals were applied, the occurrence of hypercalcemia dropped by 51% in infants and by 38% in toddlers. Across all ages, 6.1% of the subjects had actionable hypercalcemia. In children, actionable hypercalcemia was seen in those aged 5-25 months. In older individuals, actionable hypercalcemia was often secondary to another disease process. Evidence of dehydration, hypercalciuria, and nephrocalcinosis were common in both groups. Future hypercalcemia could not be reliably predicted by screening calcium levels. A subgroup analysis of 91 subjects found no associations between hypercalcemia and cardiovascular disease, gastrointestinal complaints, or renal anomalies. Analyses of electrogradiography data showed an inverse correlation of calcium concentration with corrected QT interval, but no acute life-threatening events were reported. CONCLUSIONS: Actionable hypercalcemia in patients with WBS occurs infrequently. Although irritability and lethargy were commonly reported, no mortality or acute life-threatening events were associated with hypercalcemia and the only statistically associated morbidities were dehydration, hypercalciuria, and nephrocalcinosis. Published by Elsevier Inc.
Entities:
Keywords:
calcium; not in the title: QTc; pediatric reference intervals
Authors: P Ghirri; U Bottone; L Coccoli; M Bernardini; M Vuerich; A Cuttano; C Riparbelli; G Pellegrinetti; A Boldrini Journal: J Endocrinol Invest Date: 1999-05 Impact factor: 4.256
Authors: Anke L L Lameris; Christel L M Geesing; Joost G J Hoenderop; Michiel F Schreuder Journal: J Pediatr Endocrinol Metab Date: 2014-07 Impact factor: 1.634
Authors: Sofia Shaikh; Jessica L Waxler; Hang Lee; Kathy Grinke; Jamie Garry; Barbara R Pober; Takara L Stanley Journal: Clin Endocrinol (Oxf) Date: 2018-09-18 Impact factor: 3.478
Authors: Michael Lugo; Zoë C Wong; Charles J Billington; Phoebe C R Parrish; Glennis Muldoon; Delong Liu; Barbara R Pober; Beth A Kozel Journal: Am J Med Genet A Date: 2020-02-20 Impact factor: 2.578
Authors: Paul Kruszka; Antonio R Porras; Deise Helena de Souza; Angélica Moresco; Victoria Huckstadt; Ashleigh D Gill; Alec P Boyle; Tommy Hu; Yonit A Addissie; Gary T K Mok; Cedrik Tekendo-Ngongang; Karen Fieggen; Eloise J Prijoles; Pranoot Tanpaiboon; Engela Honey; Ho-Ming Luk; Ivan F M Lo; Meow-Keong Thong; Premala Muthukumarasamy; Kelly L Jones; Khadija Belhassan; Karim Ouldim; Ihssane El Bouchikhi; Laila Bouguenouch; Anju Shukla; Katta M Girisha; Nirmala D Sirisena; Vajira H W Dissanayake; C Sampath Paththinige; Rupesh Mishra; Monisha S Kisling; Carlos R Ferreira; María Beatriz de Herreros; Ni-Chung Lee; Saumya S Jamuar; Angeline Lai; Ee Shien Tan; Jiin Ying Lim; Cham Breana Wen-Min; Neerja Gupta; Stephanie Lotz-Esquivel; Ramsés Badilla-Porras; Dalia Farouk Hussen; Mona O El Ruby; Engy A Ashaat; Siddaramappa J Patil; Leah Dowsett; Alison Eaton; A Micheil Innes; Vorasuk Shotelersuk; Ëben Badoe; Ambroise Wonkam; María Gabriela Obregon; Brian H Y Chung; Milana Trubnykova; Jorge La Serna; Bertha Elena Gallardo Jugo; Miguel Chávez Pastor; Hugo Hernán Abarca Barriga; Andre Megarbane; Beth A Kozel; Mieke M van Haelst; Roger E Stevenson; Marshall Summar; A Adebowale Adeyemo; Colleen A Morris; Danilo Moretti-Ferreira; Marius George Linguraru; Maximilian Muenke Journal: Am J Med Genet A Date: 2018-05 Impact factor: 2.578
Authors: Rossella De Cegli; Simona Iacobacci; Anthony Fedele; Andrea Ballabio; Diego di Bernardo Journal: Sci Data Date: 2019-11-06 Impact factor: 6.444